|
⚲
|
| Keyboard |
| Checkpoint Capital LP
✚
|
|
|---|---|
| CRD # | 325763 |
| SEC # | 801-134055 |
| CIK # | 0001977548 |
| AUM | 333.8 M (2026-03-27) |
| Employees | 2 (100% Investors, 0% Brokers) |
| Phone | 914-355-0570 |
| Address | 345 California Street San Francisco, CA 94104 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Argenx SE | 111.7 | ||
| Rhythm Pharmaceuticals Inc | 106.7 | ||
| Revolution Medicines Inc | 25.5 | ||
| FS Development Corp | 18.3 | ||
| Cytokinetics Inc | 11.9 | ||
| Septerna Inc | 2.4 | ||
| Crinetics Pharmaceuticals Inc | 1.5 | ||
| Trevi Therapeutics Inc | 0.6 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Checkpoint Capital Master Fund LP | [2023-06-15] | 81.2 M | 333.8 M |
| Filed 2025-04-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 333.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 333.8 |
| By Discretionary | ||
| Discretionary | 3 | 333.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 333.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 198.6 | |
| United States Persons | 135.1 | |
| Total | 3 | 333.8 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Sam Huang | Executive Officer | 3 | 2 | |
| Checkpoint Capital GP LLC | Promoter | 2 | 2 | |
| Checkpoint Capital GP LP | Promoter | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001977548] | |
| SC 13G | [0001977548] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Checkpoint Capital LP | Kala Pharmaceuticals Inc | [2023-06-15] |
| Checkpoint Capital LP | Pieris Pharmaceuticals Inc | [2023-06-12] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 254900WE08ZDOCZ66Y20 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Mutima Capital Management LLC
✚
|
NY | 337.4 M |
|
LOON Lake Capital Management LP
✚
|
MA | 336.0 M |
|
Pillsbury Lake Capital LLC
✚
|
334.9 M | |
|
Eschaton Opportunities Fund Management LP
✚
|
FL | 333.9 M |
|
Congruence Capital LLC
✚
|
CA | 333.5 M |
|
Highland Peak Capital LLC
✚
|
CT | 333.2 M |
|
Collab Currency Management LLC
✚
|
332.5 M | |
|
Oceanic Investment Management Limited
✚
|
331.5 M | |
|
Edgeworth Capital PTY Ltd
✚
|
330.9 M | |
|
Hazoor Partners LLC
✚
|
TX | 330.7 M |